Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (October 1989). "Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease". Neuron3 (4): 519–26. PMID2484340. doi:10.1016/0896-6273(89)90210-9.
Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-Yoshitake R, Takei Y, Noda T, Hirokawa N (June 1994). "Altered microtubule organization in small-calibre axons of mice lacking tau protein". Nature369 (6480): 488–91. PMID8202139. doi:10.1038/369488a0.
Taniguchi T, Kawamata T, Mukai H, Hasegawa H, Isagawa T, Yasuda M, Hashimoto T, Terashima A, Nakai M, Mori H, Ono Y, Tanaka C (March 2001). "Phosphorylation of tau is regulated by PKN". J. Biol. Chem.276 (13): 10025–31. PMID11104762. doi:10.1074/jbc.M007427200.
Kanemaru K, Takio K, Miura R, Titani K, Ihara Y (May 1992). "Fetal-type phosphorylation of the tau in paired helical filaments". J. Neurochem.58 (5): 1667–75. PMID1560225. doi:10.1111/j.1471-4159.1992.tb10039.x.
Matsuo ES, Shin RW, Billingsley ML, Van deVoorde A, O'Connor M, Trojanowski JQ, Lee VM (October 1994). "Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau". Neuron13 (4): 989–1002. PMID7946342. doi:10.1016/0896-6273(94)90264-X.
Shaw-Smith C, Pittman AM, Willatt L, Martin H, Rickman L, Gribble S, Curley R, Cumming S, Dunn C, Kalaitzopoulos D, Porter K, Prigmore E, Krepischi-Santos AC, Varela MC, Koiffmann CP, Lees AJ, Rosenberg C, Firth HV, de Silva R, Carter NP (September 2006). "Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability". Nat. Genet.38 (9): 1032–7. PMID16906163. doi:10.1038/ng1858.
Almos PZ, Horváth S, Czibula A, Raskó I, Sipos B, Bihari P, Béres J, Juhász A, Janka Z, Kálmán J (November 2008). "H1 tau haplotype-related genomic variation at 17q21.3 as an Asian heritage of the European Gypsy population". Heredity (Edinb)101 (5): 416–9. PMID18648385. doi:10.1038/hdy.2008.70.
Hardy J, Pittman A, Myers A, Gwinn-Hardy K, Fung HC, de Silva R, Hutton M, Duckworth J (August 2005). "Evidence suggesting that Homo neanderthalensis contributed the H2 MAPT haplotype to Homo sapiens". Biochem. Soc. Trans.33 (Pt 4): 582–5. PMID16042549. doi:10.1042/BST0330582.
Jensen PH, Hager H, Nielsen MS, Hojrup P, Gliemann J, Jakes R (September 1999). "alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356". J. Biol. Chem.274 (36): 25481–9. PMID10464279. doi:10.1074/jbc.274.36.25481.
Giasson BI, Lee VM, Trojanowski JQ (2003). "Interactions of amyloidogenic proteins". Neuromolecular Med.4 (1–2): 49–58. PMID14528052. doi:10.1385/NMM:4:1-2:49.
Hashiguchi M, Sobue K, Paudel HK (August 2000). "14-3-3zeta is an effector of tau protein phosphorylation". J. Biol. Chem.275 (33): 25247–54. PMID10840038. doi:10.1074/jbc.M003738200.
nih.gov
ncbi.nlm.nih.gov
Shin RW, Iwaki T, Kitamoto T, Tateishi J (May 1991). "Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues". Lab. Invest.64 (5): 693–702. PMID1903170.
Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (October 1989). "Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease". Neuron3 (4): 519–26. PMID2484340. doi:10.1016/0896-6273(89)90210-9.
Taniguchi T, Kawamata T, Mukai H, Hasegawa H, Isagawa T, Yasuda M, Hashimoto T, Terashima A, Nakai M, Mori H, Ono Y, Tanaka C (March 2001). "Phosphorylation of tau is regulated by PKN". J. Biol. Chem.276 (13): 10025–31. PMID11104762. doi:10.1074/jbc.M007427200.
Kanemaru K, Takio K, Miura R, Titani K, Ihara Y (May 1992). "Fetal-type phosphorylation of the tau in paired helical filaments". J. Neurochem.58 (5): 1667–75. PMID1560225. doi:10.1111/j.1471-4159.1992.tb10039.x.
Mawal-Dewan M, Henley J, Van de Voorde A, Trojanowski JQ, Lee VM (December 1994). "The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases". J. Biol. Chem.269 (49): 30981–7. PMID7983034.
Matsuo ES, Shin RW, Billingsley ML, Van deVoorde A, O'Connor M, Trojanowski JQ, Lee VM (October 1994). "Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau". Neuron13 (4): 989–1002. PMID7946342. doi:10.1016/0896-6273(94)90264-X.
Shaw-Smith C, Pittman AM, Willatt L, Martin H, Rickman L, Gribble S, Curley R, Cumming S, Dunn C, Kalaitzopoulos D, Porter K, Prigmore E, Krepischi-Santos AC, Varela MC, Koiffmann CP, Lees AJ, Rosenberg C, Firth HV, de Silva R, Carter NP (September 2006). "Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability". Nat. Genet.38 (9): 1032–7. PMID16906163. doi:10.1038/ng1858.
Almos PZ, Horváth S, Czibula A, Raskó I, Sipos B, Bihari P, Béres J, Juhász A, Janka Z, Kálmán J (November 2008). "H1 tau haplotype-related genomic variation at 17q21.3 as an Asian heritage of the European Gypsy population". Heredity (Edinb)101 (5): 416–9. PMID18648385. doi:10.1038/hdy.2008.70.
Hardy J, Pittman A, Myers A, Gwinn-Hardy K, Fung HC, de Silva R, Hutton M, Duckworth J (August 2005). "Evidence suggesting that Homo neanderthalensis contributed the H2 MAPT haplotype to Homo sapiens". Biochem. Soc. Trans.33 (Pt 4): 582–5. PMID16042549. doi:10.1042/BST0330582.
Klein C, Kramer EM, Cardine AM, Schraven B, Brandt R, Trotter J (February 2002). "Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau". J. Neurosci.22 (3): 698–707. PMID11826099.
Jensen PH, Hager H, Nielsen MS, Hojrup P, Gliemann J, Jakes R (September 1999). "alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356". J. Biol. Chem.274 (36): 25481–9. PMID10464279. doi:10.1074/jbc.274.36.25481.
Giasson BI, Lee VM, Trojanowski JQ (2003). "Interactions of amyloidogenic proteins". Neuromolecular Med.4 (1–2): 49–58. PMID14528052. doi:10.1385/NMM:4:1-2:49.
Hashiguchi M, Sobue K, Paudel HK (August 2000). "14-3-3zeta is an effector of tau protein phosphorylation". J. Biol. Chem.275 (33): 25247–54. PMID10840038. doi:10.1074/jbc.M003738200.
Yu WH, Fraser PE (April 2001). "S100beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease". J. Neurosci.21 (7): 2240–6. PMID11264299.
Baudier J, Cole RD (April 1988). "Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+/calmodulin-dependent protein kinase II". J. Biol. Chem.263 (12): 5876–83. PMID2833519.
oxfordjournals.org
hmg.oxfordjournals.org
Untangling the tau gene association with neurodegenerative disorders
Human Molecular Genetics (2006) 15 (suppl 2): R188-R195. doi: 10.1093/hmg/ddl190. Cita: "O xene tau humano, MAPT (MIM 157140), que abrangue ∼150 kb de secuencia de nucleótidos no cromosoma 17q21.3, const de 1 exón non codificante e 14 exóns codificantes. No cerebro humano de adultos sans, a proteína tau existe en seis isoformas producidas polo splicing alternativos dos exóns 2, 3 e 10." [1]
